BioCentury | Dec 22, 2008
Clinical News

Encore Therapeutics preclinical data

...model of analgesia. The company is seeking a development and marketing partner for the compound. Encore Therapeutics Inc....
BioCentury | Aug 6, 2007
Clinical News

Encore Therapeutics preclinical data

...the marketed formulation of ropivacaine solution, which was lethal at a dose of 54 mg/kg. Encore Therapeutics Inc....
Items per page:
1 - 2 of 2
BioCentury | Dec 22, 2008
Clinical News

Encore Therapeutics preclinical data

...model of analgesia. The company is seeking a development and marketing partner for the compound. Encore Therapeutics Inc....
BioCentury | Aug 6, 2007
Clinical News

Encore Therapeutics preclinical data

...the marketed formulation of ropivacaine solution, which was lethal at a dose of 54 mg/kg. Encore Therapeutics Inc....
Items per page:
1 - 2 of 2